Active ingredientThiotriazolinCat. No. P-T100-001CAS 357172-63-5Family · Pharmaceutical analytical standards
Thiotriazolin
A metabolic drug with antioxidant and anti-ischaemic action, the morpholinium salt of tiazotic acid (a 1,2,4-triazole derivative), developed in Ukraine by the team of Professor I. A. Mazur and approved for clinical use in 1994; it is used for stable angina, other cardiovascular diseases and in ophthalmology. This family brings together the active ingredient.
Did you know?Its molecule was selected from more than a thousand 1,2,4-triazole derivatives; the active substance can crystallise in two different forms (polymorphs).
Go to the active ingredient →Active ingredientThiotriazolinCat. No. P-T100-001CAS 357172-63-5No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.